US FDA’s Confidence In Gene Editing Safety Growing Enough That Regulatory Bar May Be Lowered

 
• By Derrick Gingery
Peter Marks (third from left) at the NORD Breakthrough Summit
CBER Director Peter Marks (third from left) speaks about gene therapy during the NORD Breakthrough Summit. • Source: National Organization for Rare Disorders (NORD)

More from Cell & Gene Therapies

More from Advanced Technologies